Beijing Balance Medical Technology Co

Beijing Balance Medical Technology Co Interest Coverage

The Interest Coverage Ratio of Beijing Balance Medical Technology Co (688198.SS) as of Nov 2, 2026 is 7.82. In the previous year, Interest Coverage Ratio was 5.80 — a change of 34.91% (higher).

Interest Coverage

7.82

YoY

34.91%

Last updated:

Interest Coverage Ratio of Beijing Balance Medical Technology Co is 2024 7.82 . Interest Coverage Ratio of Beijing Balance Medical Technology Co was 2023 5.80 . It decreases by 34.91% higher compared to the previous year.

The Beijing Balance Medical Technology Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
71.54 CNY
Jan 1, 2018
17.84 CNY
Jan 1, 2019
42.47 CNY
Jan 1, 2020
2.45 CNY
Jan 1, 2021
2.08 CNY
Jan 1, 2022
3.68 CNY
Jan 1, 2023
5.80 CNY
Jan 1, 2024
7.82 CNY
The Beijing Balance Medical Technology Co Interest Coverage history
YEARInterest CoverageYoY
7.82+34.91%
5.80+57.63%
3.68+76.63%
2.08-15.07%
2.45-94.23%
42.47+138.02%
17.84-75.06%
71.54-80.77%
372.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Balance Medical Technology Co Stock analysis

What does Beijing Balance Medical Technology Co do? Beijing Balance Medical Technology Co., Ltd. generates revenue through the manufacture and sale of biotechnology products across three key therapeutic areas. The company's heart valve replacement and repair segment offers artificial biological heart valves and valve forming rings, while its congenital heart disease interventional therapy line includes cardiothoracic surgical biological patches, outflow tract single valve patches, and atrial defect occluders. The surgical soft tissue repair division provides neurosurgical biological patches and biological hernia patches. All products are sold primarily within China's domestic market to hospitals and medical institutions seeking advanced cardiovascular and surgical solutions. The firm's product portfolio targets medical professionals specializing in cardiac surgery, congenital heart defect correction, and soft tissue repair procedures. Hospitals and healthcare providers in China purchase these biotechnology solutions for patient treatments, with the domestic market serving as the primary sales channel. The company's focus on specialized medical devices for heart valve procedures, congenital heart conditions, and surgical repair applications drives its revenue streams. Beijing Balance Medical Technology's business model centers on developing and distributing high-precision medical devices tailored to specific surgical needs. The domestic Chinese healthcare system represents the main customer segment, with hospitals and clinics purchasing the company's products for use in cardiac surgeries, congenital heart defect corrections, and soft tissue repair operations. The company's product range directly supports medical procedures requiring biological heart valves, congenital heart disease interventions, and surgical tissue repair solutions. Beijing Balance Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Balance Medical Technology Co stock

Interest Coverage Ratio of Beijing Balance Medical Technology Co is 7.82 in 2024.

Interest Coverage Ratio of Beijing Balance Medical Technology Co changed from 5.80 to 7.82, representing a 34.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Beijing Balance Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Beijing Balance Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Beijing Balance Medical Technology Co

All Key Metrics — Beijing Balance Medical Technology Co